Company Filing History:
Years Active: 2024
Title: Elisabet C Mandon: Innovator in Gene Therapy
Introduction
Elisabet C Mandon is a prominent inventor based in Shrewsbury, MA (US). She has made significant contributions to the field of gene therapy, particularly through her innovative research and patents. Her work focuses on the use of adeno-associated virus serotypes in gene therapy vectors, which has the potential to advance medical treatments.
Latest Patents
Elisabet holds a patent titled "Use of inverted terminal repeats (ITRS) from adeno-associated virus serotypes 8 and RH.39 in gene therapy vectors." This patent describes recombinant AAV and nucleic acid constructs that feature novel inverted terminal repeats, cap, and/or rep genes. The disclosure also relates to gene transfer methods using the recombinant AAVs described in her patent.
Career Highlights
Elisabet is affiliated with the University of Massachusetts, where she conducts her research and development in gene therapy. Her work has garnered attention for its innovative approach to utilizing viral vectors for therapeutic purposes.
Collaborations
Elisabet has collaborated with notable researchers in her field, including Guangping Gao and Phillip Tai. These partnerships have contributed to the advancement of her research and the development of new methodologies in gene therapy.
Conclusion
Elisabet C Mandon is a trailblazer in the field of gene therapy, with her innovative patent and collaborative efforts paving the way for future advancements in medical treatments. Her contributions are significant and continue to impact the scientific community.